The global endoscopy equipment market, valued at US $34.83 billion in 2024, rose to US $37.08 billion in 2025, and is projected to expand at a CAGR of 7.6 % from 2025 to 2030, reaching an estimated US $53.54 billion by the end of the forecast period.
What’s fueling this growth?
-
Growing demand for endoscopic procedures in diagnosing and treating serious conditions drives market expansion.
-
Increased government and organizational investments and grants support new equipment adoption.
-
Rising prevalence of inflammatory bowel disease (IBD) and colorectal cancer adds pressure for diagnostics and intervention.
-
Hospitals and surgical centers are scaling endoscopic capabilities, propelled by the shift to minimally invasive procedures and technological advances.
-
Accelerated uptake of single-use endoscopy instruments and automated endoscope reprocessing solutions reduces infection risk, increases throughput, and satisfies stringent hygiene regulations.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689
Segmentation – Products & Applications
Product Landscape
The market is segmented into: endoscopes, visualization systems, other endoscopy equipment, and accessories. Within endoscopes: rigid, flexible, robot-assisted, and capsule endoscopes.
-
In 2024, the rigid endoscope segment held a dominant share and is forecast to maintain leadership through the period.
-
Within surgical applications, laparoscopy remains the largest market due to its broad adoption across minimally invasive surgeries.
-
Meanwhile, bronchoscopy is expected to record the fastest growth, driven by the rising burden of respiratory diseases including lung cancer.
-
Laparoscopy’s widespread adoption is rooted in its clinical advantages: smaller incisions, lower surgical-site infection (SSI) risk, shorter hospital stays, and faster patient recovery — making it increasingly the preferred option over open surgery.
-
The rising incidence of gastrointestinal disorders and urinary system complications further fuels laparoscopic interventions. For example, laparoscopic cholecystectomy has become a safe, cost-effective alternative to open gallbladder removal, reinforcing the segment’s dominance.
Application Landscape
By application, the market is divided into: gastrointestinal endoscopy, bronchoscopy, ENT endoscopy, urology (cystoscopy), laparoscopy, obstetrics/gynecology endoscopy, arthroscopy, mediastinoscopy, and other niches.
-
The bronchoscopy segment is projected to grow at the fastest pace during the forecast period. This is driven by:
-
A rising global burden of respiratory diseases – including lung cancer. For instance, in the U.S. in 2025, approximately 226,650 new lung cancer cases and 124,730 deaths are expected according to the American Cancer Society.
-
Bronchoscopes are deployed for both diagnostic and therapeutic purposes — tissue biopsy, airway examination, stent placement, foreign-body removal.
-
The shift toward minimally invasive techniques, and increased adoption of video and disposable bronchoscopes, support segment growth.
-
The increasing prevalence of chronic respiratory conditions such as COPD, asthma, and infections, along with growing demand for same-day outpatient bronchoscopy, reinforces this growth trajectory.
-
Geographic Trends
Geographically, the market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
-
North America commanded the largest share in 2024. Contributing factors include:
-
High prevalence of chronic diseases and large procedural volumes. For example, in the U.S. about 2,001,140 new cancer diagnoses and 611,720 cancer-related deaths were reported in 2024.
-
Gastrointestinal disorders remain highly prevalent — a May 2025 article noted that 23.5 million GI endoscopies were performed in 2022.
-
Strong research funding: e.g., the National Institutes of Health (NIH) allocated USD 3.6 billion to GI research in 2023 (approx. 7.4 % of its total budget).
-
Advanced healthcare infrastructure, favourable reimbursement policies, and rapid uptake of minimally invasive technologies further bolster the region’s dominance.
-
Presence of leading global manufacturers and continuous innovation (AI-integrated endoscopes, disposable variants) improve accessibility and efficiency, reinforcing North America’s position as the largest revenue-generating region.
-
Summary
In summary, the endoscopy equipment market is witnessing robust growth, driven by disease prevalence, demand for minimally invasive procedures, investment, and technological innovations. With the rigid endoscope segment currently dominant, and bronchoscopy poised for fastest growth, the expansion across applications and regions promises considerable opportunity for manufacturers, healthcare providers, and investors.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=689